blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3514543

EP3514543 - QUANTITATIVE CONTROLS AND CALIBRATORS FOR CELLULAR ANALYTES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.03.2022
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  03.04.2021
FormerGrant of patent is intended
Status updated on  16.11.2020
FormerExamination is in progress
Status updated on  17.03.2020
FormerRequest for examination was made
Status updated on  24.01.2020
FormerThe application has been published
Status updated on  21.06.2019
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Boston Cell Standards LLC
800 Washington Street
Box 115
Boston, MA 02111 / US
[2020/10]
Former [2019/30]For all designated states
Medical Discovery Partners LLC
800 Washington Street
Box 115
Boston, MA 02111 / US
Inventor(s)01 / SOMPURAM, Seshi R
148 Winchester Road
Arlington, MA 02474 / US
02 / BOGEN, Steven A
35 Cheryl Drive
Sharon, MA 02067 / US
 [2019/30]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2019/30]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date19159269.007.11.2014
[2019/30]
Priority number, dateUS201361901394P07.11.2013         Original published format: US 201361901394 P
[2019/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3514543
Date:24.07.2019
Language:EN
[2019/30]
Type: B1 Patent specification 
No.:EP3514543
Date:05.05.2021
Language:EN
[2021/18]
Search report(s)(Supplementary) European search report - dispatched on:EP18.04.2019
ClassificationIPC:G01N33/543
[2019/30]
CPC:
G01N33/54313 (EP,US); G01N1/30 (US); G01N1/312 (US);
G01N2001/2893 (US); G01N2496/00 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/09]
Former [2019/30]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:QUANTITATIVE STEUERUNGEN UND KALIBRATOREN FÜR ZELLULÄRE ANALYTEN[2019/30]
English:QUANTITATIVE CONTROLS AND CALIBRATORS FOR CELLULAR ANALYTES[2019/30]
French:TÉMOINS QUANTITATIFS ET ÉTALONNEURS POUR ANALYTES CELLULAIRES[2019/30]
Examination procedure21.01.2020Amendment by applicant (claims and/or description)
21.01.2020Examination requested  [2020/09]
21.01.2020Date on which the examining division has become responsible
20.03.2020Despatch of a communication from the examining division (Time limit: M04)
15.07.2020Reply to a communication from the examining division
17.11.2020Communication of intention to grant the patent
25.03.2021Fee for grant paid
25.03.2021Fee for publishing/printing paid
25.03.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14859458.3  / EP3065704
Divisional application(s)EP21165034.6  / EP3869196
Opposition(s)08.02.2022No opposition filed within time limit [2022/15]
Fees paidRenewal fee
26.02.2019Renewal fee patent year 03
26.02.2019Renewal fee patent year 04
26.02.2019Renewal fee patent year 05
27.11.2019Renewal fee patent year 06
27.11.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.11.2014
AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
MK05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
IE07.11.2021
LU07.11.2021
[2024/23]
Former [2023/33]HU07.11.2014
AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
IE07.11.2021
LU07.11.2021
Former [2023/30]AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
IE07.11.2021
LU07.11.2021
Former [2022/48]AL05.05.2021
AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
IE07.11.2021
LU07.11.2021
Former [2022/34]AL05.05.2021
AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
LU07.11.2021
Former [2022/33]AL05.05.2021
AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/29]AL05.05.2021
AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/26]AL05.05.2021
AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/23]AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/10]AT05.05.2021
CZ05.05.2021
EE05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
PT06.09.2021
IS22.12.2021
Former [2022/09]AT05.05.2021
CZ05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/08]AT05.05.2021
CZ05.05.2021
ES05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/07]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/04]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/52]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/51]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/50]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
PT06.09.2021
Former [2021/49]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
Former [2021/46]AT05.05.2021
FI05.05.2021
LT05.05.2021
BG05.08.2021
Documents cited:Search[A]WO0062064  (CYTOLOGIX CORP [US]) [A] 1-25 * the whole document *;
 [A]WO03089922  (AMERICAN NAT RED CROSS [US]) [A] 1-25 * example 1; claims 1-32 *;
 [A]US2007141723  (SOMPURAM SESHI A [US], et al) [A] 1-25 * paragraph [0152] - paragraph [0182]; claims 1-20 *;
 [A]WO2012054901  (UNIV SOUTHERN CALIFORNIA [US], et al) [A] 1-25* the whole document *
by applicantUS6855490
 US7011940
    - RHODES, A. et al., "Evaluation of HER2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors", Anat. Pathol., (20020000), vol. 118, pages 408 - 417
    - RHODES, A. et al., "A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer", Amer. J. Clin. Pathol., (20020000), vol. 117, doi:doi:10.1309/4NCM-QJ9W-QM0J-6QJE, pages 81 - 89, XP002660754

DOI:   http://dx.doi.org/10.1309/4NCM-QJ9W-QM0J-6QJE
    - RIERA, J. et al., "Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer", Amer. J. Clin. Pathol., (19990000), vol. 111, pages 329 - 335
    - HAMMOND, M. et al., "Standard reference material for Her2 testing: Report of a National Institute of Standards and Technology-sponsored consensus workshop", Appl. Immunohistochem. & Mol. Morphol., (20030000), vol. 11, no. 2, pages 103 - 106
    - SOMPURAM, S; V KODELA; H RAMANATHAN; C WESCOTT; G RADCLIFFE; SA BOGEN, "Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality control targets", Clin. Chem., (20020000), vol. 48, no. 3, pages 410 - 420
    - SOMPURAM, S; V KODELA; K ZHANG; H RAMANATHAN; G RADCLIFFE; P FALB; SA BOGEN, "A novel quality control slide for quantitative immunohistochemistry testing", J. Histochem. Cytochem., (20020000), vol. 50, pages 1425 - 34
    - SOMPURAM, S; V KODELA; H RAMANATHAN; C WESCOTT; G RADCLIFFE; SA BOGEN, "Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality control targets", Clinical Chemistry, (20020000), vol. 48, no. 3, pages 410 - 420
    - SOMPURAM SR; K VANI; LJ HAFER; SA BOGEN, "Antibodies Immunoreactive With Formalin-Fixed Tissue Antigens Recognize Linear Protein Epitopes", Am. J. Clin. Pathol., (20060000), vol. 125, pages 82 - 90
    - A-S SCHROHL; H.C. PEDERSEN; S.S. JENSEN, "Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies", Histopathology, (20110000), vol. 59, doi:doi:10.1111/j.1365-2559.2011.04034.x, pages 975 - 983, XP002724736

DOI:   http://dx.doi.org/10.1111/j.1365-2559.2011.04034.x
    - T SUGITA; M KATAYAMA; M OKOCHI; R KATO; T ICHIHARA; H HONDA, "Screening of peptide ligands that bind to the Fc region of IgG using peptide array and its application to affinity purification of antibody", Biochem Eng J, (20130000), vol. 79, doi:doi:10.1016/j.bej.2013.06.017, pages 33 - 40, XP028733013

DOI:   http://dx.doi.org/10.1016/j.bej.2013.06.017
    - KING S.M.; QUARTUCCIO S.; HILLIARD T.S.; INOUE K.; BURDETTE J.E., "Alginate Hydrogels for Three-Dimensional Organ Culture of Ovaries and Oviducts", JoVE., vol. 52, (20110000), page 2, URL: http://www.jove.com/details.php?id=2804
    - S-R SHI; C LIU; J PEREZ; CR TAYLOR, "Protein-embedding Technique: A Potential Approach to Standardization of Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue Sections", JHistochem Cytochem, (20050000), vol. 53, page 1168
    - MC MOTA; P CARVALHO; J RAMALHO; E LEITE, "Spectrophotometric analysis of sodium fluorescein aqueous solutions. Determination of molar absorption coefficient", International Ophthalmology, (19910000), vol. 15, pages 321 - 326
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.